Search Results

B1 (ADGRB1/BAI1) Generated from an Alternative Promoter in Intron 17 The adhesion-GPCR ADGRF5 fuels breast

Mandibulofacial dysostosis with alopecia results from ETAR gain-of-function mutations via allosteric

Research UK announce first patient dosed with oral immunotherapy drug Trevena Reports Second Quarter 2023 Results

The choice of pathway can result in different cellular responses, underscoring the criticality of precise

Therapeutic Development in Gastrointestinal Diseases Sosei Heptares Operational Highlights and Consolidated Results

Exscientia is the Sniper of the AI Drug Discovery Industry Indivior Announces Q2/H1 2023 Financial Results

(c)(4) Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2024 Financial Results

These agonists exhibit less interaction with ECL3, resulting in an open conformation of the TM6-ECL3-

the role of Chief Scientific Officer Crinetics Reports Fourth Quarter And Full Year 2023 Financial Results

Mutagenesis involves deliberately altering the DNA sequence of a gene to study the resulting changes

options, muscle preservers Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2023 Financial Results

complex, which is essential for the fusion of the synaptic vesicle membrane with the target membrane, resulting

raises FY 2024 bottom-line guidance Crinetics Pharmaceuticals to Report Second Quarter 2024 Financial Results

. 👉 While your team highlights compelling results , the FDA is already thinking differently.

Mechanism for Microbiota Effects on the Immune System, and Western Diseases Lactate receptor GPR81 drives breast

Lim TRUQAP™ (capivasertib) plus fulvestrant approved in the US for patients with advanced HR-positive breast

(GPCRs): a historical perspective Industry News Addex Therapeutics Reports Full Year 2023 Financial Results

Industry insights:  The latest on how AI is being used to unlock elusive GPCR targets, financial results

Beyond Biotech Podcast Crinetics Pharmaceuticals Reports Fourth Quarter And Full Year 2022 Financial Results

clinic Novo strikes another obesity drug deal Sosei Heptares Webinar Presentation for FY2023 Financial Results

As a result, intellectual property is no longer something that comes up late in the process. 👉 It has

Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2023 Financial Results

The result is a recurring pattern across programs—clean data that is not actually telling the truth.

in GPCR modeling , where his group uses structure-based techniques not just to explain experimental results

AlphaFold2 structures guide prospective ligand discovery Industry News Roche reports positive Phase Ib results

Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration

Oncogenic signaling of the free-fatty acid receptors FFA1 and FFA4 in human breast carcinoma cells.

global ranking for Pharmacy and Pharmacology Addex Therapeutics to Release Full-Year 2023 Financial Results

could be achieved by merging both orthosteric and allosteric pharmacophores within a single compound, resulting

neuropathic pain and chronic inflammation Developmental exposures to common environmental pollutants result